UMBI Spins Out Plasmonix to Commercialize Metal-Enhanced Fluorescence Tech | GenomeWeb

By Ben Butkus

This article was originally published on Aug. 18.

The University of Maryland Biotechnology Institute said this week that it has exclusively licensed a portfolio of patents covering metal-enhanced fluorescence to spinout company Plasmonix, which hopes to commercialize the technology for a number of life-science and other applications.

The deal comes as UMBI, a campus of the University System of Maryland, is restructuring to parse out various pieces of itself to other UM campuses.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.